SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox

MT Newswires Live

2025/01/02

SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).

The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.

SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.

Shares of SIGA were up 6% in recent Thursday premarket activity.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2500925779"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2500925779\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2500925779?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-02 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2500925779","market":"nz","top_or_hot":-1,"title":"SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox","media":"MT Newswires Live","content":"<html><body><p> SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).</p><p>The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.</p><p>SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.</p><p>Shares of SIGA were up 6% in recent Thursday premarket activity.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-02 21:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).</p><p>The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.</p><p>SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.</p><p>Shares of SIGA were up 6% in recent Thursday premarket activity.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SIGA","symbol_name":"SIGA Technologies Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2500925779","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2500925779","pubTimestamp":1735823708,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"SIGA Technologies  said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms .The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.Shares of SIGA were up 6% in recent Thursday premarket activity.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SIGA":"SIGA Technologies Inc","BK4007":"制药","BK4583":"猴痘概念"},"translate_title":"SIGA Technologies表示日本药品监管机构批准其针对天花、MPox、牛痘的抗病毒治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SIGA":1},"content_text":"SIGA Technologies (SIGA) said Thursday its antiviral treatment TEPOXX has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, and complications from smallpox vaccinations in patients weighing at least 13 kilograms (28.7 pounds).The drug, also called tecovirimat and marketed as TPOXX in the US, received approval from Japan's Pharmaceuticals and Medical Devices Agency, and will be distributed in partnership with Japan Biotechno Pharma, the company said.SIGA said it has already delivered an order of TEPOXX to help build Japan's strategic stockpile.Shares of SIGA were up 6% in recent Thursday premarket activity.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}